News
AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.
Keep up to date on AgNovos events and related news
During Alterstramatologie congress, Dr. Christian Fang presented a poster featuring the interim results of the ongoing STRONG clinical study.
At the ORS 2018 Annual Meeting in New Orleans, Dr. Jonathan Shaul (PhD), AgNovos Sr. Research Engineer, was selected as a finalist for both the New Investigator Recognition Award (NIRA) and ORS Preclinical Models Section Member Podium Award for his presentation: "Injectable Triphasic Biomaterial Resorbs and Increases Bone Formation in Ovariectomized Rat Metaphyseal Defects of the Femur".
AgNovos Healthcare is pleased to announce that it has hired Falk Dukatz as Vice President of Global Sales.
During the Ortomed Conference in Florence, Italy, Dr. James Howe will present the rationale and the science supporting OSSURE LOEP (Local Osteo-Enhancement Procedure), an emerging treatment for osteoporosis-related bone loss in the proximal femur.
During DKOU (German Congress of Orthopedic and Trauma Surgery), Dr James Howe will deliver a lecture on OSSURE LOEP technique, an emerging treatment for osteoporotic bone loss in the proximal femur.
During DKOU (German Congress of Orthopedic and Trauma Surgery) AgNovos will sponsor a symposium introducing OSSURE LOEP, a promising new minimally-invasive treatment to address osteoporotic bone loss in the proximal femur.